Impact of Antipsychotic Review and Nonpharmacological Intervention on Antipsychotic Use, Neuropsychiatric Symptoms, and Mortality in People With Dementia Living in Nursing Homes: A Factorial Cluster-Randomized Controlled Trial by the Well-Being and Health for People With Dementia (WHELD) Program

被引:97
作者
Ballard, Clive [1 ]
Orrell, Martin
Sun YongZhong
Moniz-Cook, Esme
Stafford, Jane
Whittaker, Rhiannon
Woods, Bob
Corbett, Anne
Garrod, Lucy
Khan, Zunera
Woodward-Carlton, Barbara
Wenborn, Jennifer
Fossey, Jane
机构
[1] Kings Coll London, Wolfson Ctr Age Related Dis, London WC2R 2LS, England
基金
美国国家卫生研究院;
关键词
PSYCHOLOGICAL SYMPTOMS; ALZHEIMER-DISEASE; PHYSICAL-ACTIVITY; CARE; AGITATION; MANAGEMENT; INVENTORY; DRUGS; RISK;
D O I
10.1176/appi.ajp.2015.15010130
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: This study evaluated the impact of antipsychotic review, social interaction, and exercise, in conjunction with person-centered care, on antipsychotic use, agitation, and depression in people with dementia living in nursing homes. Method: A cluster-randomized factorial controlled trial with two replications was conducted in people with dementia in 16 U.K. nursing homes. All homes received training in person-centered care. Eight homes were randomly assigned to antipsychotic review, to a social interaction intervention, and to an exercise intervention for 9 months, with most homes assigned to more than one intervention. The primary outcome measures were antipsychotic use, agitation, and depression. Secondary outcome measures were overall neuropsychiatric symptoms and mortality. Results: Antipsychotic review significantly reduced antipsychotic use by 50% (odds ratio 0.17, 95% confidence interval [CI] 0.05 to 0.60). Antipsychotic review plus the social interaction intervention significantly reduced mortality (odds ratio 0.26, 95% CI 0.13 to 0.51) compared with the group receiving neither. The group receiving antipsychotic review but not the social intervention showed significantly worse outcome in neuropsychiatric symptoms compared with the group receiving neither (score difference +7.37, 95% CI 1.53 to 13.22). This detrimental impact was mitigated by concurrent delivery of the social intervention(-0.44, CI -4.39 to 3.52). The exercise intervention significantly improved neuropsychiatric symptoms (-3.59, 95% CI -7.08 to -0.09) but not depression (-1.21, CI -4.35 to 1.93). None of the interventions had a significant impact specifically on agitation. Conclusions: While reductions in antipsychotic use can be achieved by using a "real world" intervention, this may not be of benefit to people with dementia in the current climate of more judicious prescribing unless nonpharmacological interventions such as social interaction or exercise are provided in parallel.
引用
收藏
页码:252 / 262
页数:11
相关论文
共 40 条
[1]   CORNELL SCALE FOR DEPRESSION IN DEMENTIA [J].
ALEXOPOULOS, GS ;
ABRAMS, RC ;
YOUNG, RC ;
SHAMOIAN, CA .
BIOLOGICAL PSYCHIATRY, 1988, 23 (03) :271-284
[2]  
All Party Parliamentary Group on Dementia, ALW LAST RES INQ PRE
[3]  
Alzheimer's Disease International, WORLD ALZH REP 2013
[4]  
[Anonymous], DEM SUPP PEOPL DEM T
[5]  
Ballard CG, 2004, J CLIN PSYCHIAT, V65, P114
[6]   A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial) [J].
Ballard, Clive ;
Lana, Marisa Margallo ;
Theodoulou, Megan ;
Douglas, Simon ;
McShane, Rupert ;
Jacoby, Robin ;
Kossakowski, Katja ;
Yu, Ly-Mee ;
Juszczak, Edmund .
PLOS MEDICINE, 2008, 5 (04) :587-599
[7]   Neuroleptic drugs in dementia: benefits and harm [J].
Ballard, Clive ;
Howard, Robert .
NATURE REVIEWS NEUROSCIENCE, 2006, 7 (06) :492-500
[8]   Atypical antipsychotics for the treatment of behavioral and psychological symptoms in dementia, with a particular focus on longer term outcomes and mortality [J].
Ballard, Clive ;
Creese, Byron ;
Corbett, Anne ;
Aarsland, Dag .
EXPERT OPINION ON DRUG SAFETY, 2011, 10 (01) :35-43
[9]   The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial [J].
Ballard, Clive ;
Hanney, Maria Luisa ;
Theodoulou, Megan ;
Douglas, Simon ;
McShane, Rupert ;
Kossakowski, Katja ;
Gill, Randeep ;
Juszczak, Edmund ;
Yu, Ly-Mee ;
Jacoby, Robin .
LANCET NEUROLOGY, 2009, 8 (02) :151-157
[10]   Management of agitation and aggression associated with Alzheimer disease [J].
Ballard, Clive G. ;
Gauthier, Serge ;
Cummings, Jeffrey L. ;
Brodaty, Henry ;
Grossberg, George T. ;
Robert, Philippe ;
Lyketsos, Constantine G. .
NATURE REVIEWS NEUROLOGY, 2009, 5 (05) :245-255